Content Navigation
( All
None )
| Target and Pathway |
Top |
| Target(s) |
Peroxisome proliferator-activated receptor (PPAR) |
Target Info
|
Agonist |
[2] |
| References |
Top |
| REF 1 |
ClinicalTrials.gov (NCT03008070) Phase 2b Study in NASH to Assess IVA337 (NATIVE). U.S. National Institutes of Health.
|
| REF 2 |
Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension. Ann Rheum Dis. 2017 Nov;76(11):1931-1940.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.
